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Abstract: Background: Knowledge of radiobiology is of paramount importance to be able to grasp and 
have an in-depth understanding of the consequences of ionizing radiation. One of the most important 
effects of this physical stressor’s interaction to targeted and non-targeted cells, tissues and organs is on 
the late effects on the development of primary and secondary cancers. Thus, an in-depth understanding 
of the mechanisms of radiation carcinogenesis remains to be elucidated, and some studies have demon-
strated or proposed a role of non-targeted effect in excess risk of cancer incidence. The non-targeted 
effect in radiobiology refers to a dynamic complex response in non-irradiated tissues caused by the re-
lease of presumably of clastogenic factors from irradiated cells. Although, most of these responses in 
non-targeted tissues have marked similarities to irradiated tissues, other studies have shown some dif-
ferences. Also, the non-targeted effect has shown sex and tissue specificity that are seen in irradiated 
tissues too. So far, several studies have been conducted to depict mechanisms that may be involved in 
this phenomenon. Epigenetic dysfunctions, DNA damage and cell death are responsible for initiation of 
several signaling pathways that finally result in secretion of clastogenic factors. Moreover, studies have 
shown that damage to both nucleus and mitochondrial DNA, membrane and some organelles is  in-
volved. Oxidized DNA associated with other cell death factors stimulates secretion of inflammatory as 
well as some anti-inflammatory cytokines from irradiated area. Additionally, oxidative stress that results 
in damage to cellular structures to include cell membranes can affect secretion of exosomes and miR-
NAs. These bystander effect exogenous mediators migrate to distant tissues and stimulate various sig-
naling pathways which can lead to changes in immune responses, epigenetic modulations and radiation 
carcinogenesis.  
Conclusion: In this review, we focus on descriptive and hierarchical events with emphasis on the mo-
lecular and functional interactions of ionizing radiation with cells to the mechanisms involved in cancer 
induction in non-targeted tissues. 
Keywords: Radiation, radiation carcinogenesis, radiotherapy, systemic effect, bystander effect, non-targeted effect, epigenet-
ics, DNA damage, clastogenic factors, cell cycle. 
1. INTRODUCTION 
 Irradiation of cells and tissues generates a series of proc-
esses that occur in nanoseconds. The first event is the bio-
physical interaction between radiation and cells. The colli-
sion between radiation and atoms of viable cells results in  
the ejection of the electrons and ionization. The ionization  
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event is the first step that induces  damage in the cells result-
ing from unstable molecules and cellular and molecular trig-
gered malfunctions. For many years it has been accepted that 
the DNA is the most critical target for the interaction of ion-
izing radiation and its produced free radicals. Moreover, it 
was accepted that DNA damage occurs instantaneously after 
radiation interaction. In the last two decades, the classical 
nuclear target paradigm of radiation biology is challenged by 
the non-targeted effect of radiation. This phenomenon has 
been widely investigated by several scientists, to include the 
effects of ionizing radiation that is seen in the cells or tissues 
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that are  not directly exposed to ionizing radiation track [1]. 
This phenomenon results in systemic DNA damage and also 
in some abnormal changes in the cell functions following 
local irradiation [2-4].  
 There are some suggestions that non-targeted effect 
causes permanent changes in DNA structure that can be 
transferred to the succeeding generations as well [5-7]. 
Evaluating epigenetic landmarks has shown that local irra-
diation results in hypomethylation, and also in upregulation 
or downregulation of some microRNAs (miRNAs) in non-
targeted tissues. Upregulation and downregulation of miR-
NAs involved in the expression of oncogenes and tumor 
suppressor genes such as let-7 miRNAs may increase the 
risk of malignancies. Although, epigenetic changes depend 
on sex, irradiated and non-targeted organs and tissues [8-10]. 
 Another important change in non-targeted tissues that 
may be linked to secondary carcinogenesis is the increased 
level of some inflammatory cytokines [11]. Inflammation 
has a direct link to carcinogenesis [12]. Increased inflamma-
tory markers are associated with continuous reactive oxygen 
species (ROS) and nitric oxide (NO-) production which re-
sult in chromosome aberrations and genomic instability [13-
15]. Moreover, it seems that there is a direct connection of 
inflammation and epigenetic changes [16, 17].  
 Radiation-induced carcinogenesis potential and  non-
targeted effects were studied by Mancuso et al. They showed 
that irradiation of shielded brains Ptch1+/ mice resulted in 
increased incidence of medulloblastoma. Elevated incidence 
of this cancer was associated with DNA damage including 
double strand break (DSB) and chromosome-13 interstitial 
deletions in actively dividing cells [18]. Analysis of the sec-
ond primary cancer among people that have had radiotherapy 
for cancer has shown that abnormally increased cancer in out 
of filed organs may be related to non-targeted effect [19-22]. 
 In view of these observations, radiotherapy for cancer is 
now being done localized as in external radiotherapy or 
brachytherapy, with the view that systemic effects of radia-
tion increase concerns for potential carcinogenesis in distant 
tissues. As secondary malignancies affect cost-effectiveness, 
the therapeutic efficacy and value of radiotherapy, it is im-
portant to consider all factors that may influence the risk of 
radiation induced carcinogenesis [23]. This issue is more 
important for pediatric radiotherapy because of their higher 
radiosensitivity, and life expectancy for children. Some stud-
ies revealed up to 23 fold excess risk of secondary brain ma-
lignancy in children treated with radiotherapy [24, 25]. One 
study has shown that that risk of the second primary cancers 
is 10-fold for children in comparison with adults [26]. 
Bystander responses have been investigated in targeted 
radionuclide therapy. Boyd et al. in an in vitro experiment 
studied bystander effect for both external beam irradiation 
and exposure to 3 different radionuclides. They used a -, 
auger electron, and -emitter radionuclides in human glioma 
and bladder carcinoma cell lines. Their result indicated that 
bystander effect for radionuclides with higher LET auger 
electron and -particle was more obvious compared to elec-
tron irradiation [27]. Incidence of in vivo bystander re-
sponses for tumor bearing mice that injected with 
125
IUdR-
labeled tumor cells has also been confirmed [28]. 
2. MOLECULAR BASES OF RADIATION INTERAC-
TIONS: 
2.1. Radiation-Induced DNA Damage, Cell Death and 
Tissue Injury 
 Although a complete description of the mechanisms in-
volved in radiation bystander-non-targeted effect is missing, 
it seems that direct and indirect DNA-mediated damage re-
sponses, and its consequences following cell injury or death 
in the initial irradiated target area are primarily responsible 
for DNA damage and genomic instability in non-targeted 
cells. As DNA damage and genomic instability have a direct 
link to carcinogenesis, the non-targeted effect may increase 
the risk of second primary malignancies [29]. In addition to 
the increased risk of second malignancies, some studies have 
reported that non-targeted effect can result in normal tissue 
injury [30, 31].  
 DNA is the most critical target for ionizing radiation or 
free radical production. In addition to nuclear DNA, ionizing 
radiation can to break mitochondrial DNA and disrupt its 
normal function through the production of free radicals. Indi-
rect generation of free radicals interacts with DNA, mem-
brane, lipids and proteins. Oxidation of these macromole-
cules results in direct DNA damage, increasing membrane 
permeability and thus changing normal function of cells 
[32]. Massive DNA damage that is seen following exposure 
to clinical doses of ionizing radiation causes cellular death, 
either thru apoptosis, mitotic catastrophe, and necrosis and 
autophagy. Among these, cell death mechanisms, necrosis 
and apoptosis stimulate immune system responses through 
secretion of danger alarms. These signals known as damage-
associated molecular patterns (DAMPs) are recognized 
through pattern recognition receptor (PRRs) [33, 34]. The 
most known PRRs in this pathway are named as toll like 
receptors (TLRs). Although several TLRs are known, it 
seems that TLR2, TLR4 and TLR9 are most important PRRs 
in response to cell death after irradiation [35]. These PRRs 
upregulate the expression of transcription factors such as 
NF-B, STAT-1, STAT-3 and smad2 that result in secretion 
of various cytokines from immune cells [35, 36]. The role of 
sensitive molecular signaling and molecular receptors in 
radiation-mediated cell deaths and cell injury needs further 
understanding of  their functions in correlating their utility 
for clinical radiotherapy and drug and gene targeted thera-
peutics discovery and applications. 
2.2. Role of Cytoplasm and Membrane  
 Although DNA is the most critical target for radiation 
injury in cells, emerging evidence have proposed that irradia-
tion of cytoplasm can lead to damage to direct irradiated or 
bystander cells. Several years ago, it has been reported that 
irradiation of cytoplasm can cause generation of toxin agents 
that are able to diffuse into the non-irradiated nucleus, lead-
ing to inhibition of DNA synthesis [37]. Nowadays, mi-
crobeam irradiation studies can identify biological response 
of cytoplasm after localized irradiation. Prise et al. showed 
that localized cytoplasm irradiation with alpha particles can 
cause induction of DNA damage in irradiated and bystander 
cells. They showed that DNA damage in bystander effect can 
be identified from 1 h to 3 h after irradiation. Also, their re-
sults showed that the inhibition of mitochondria attenuates 
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free radical production and DNA damage in bystander cells. 
In conclusion, their results indicated that the irradiation of 
cytoplasm through stimulation of mitochondria can trigger 
the production of ROS and NO in non-irradiated cells. 
Moreover, this study showed that induction of bystander 
effect in non-irradiated cell is independent of the number of 
irradiated cells or the numbers of alpha particles. Also it has 
been shown that bystander responses are independent of  
whether cytoplasm or nucleus irradiates with alpha particles 
[38]. This group showed that when one alpha particle irradi-
ated to cytoplasm of glioma cells, the formation of micronu-
clei is increased in non-irradiated glioma or fibroblast cells. 
The formation of micronuclei was more obvious by twofold 
for fibroblast cells. Their results confirmed that NO has a 
key role in DNA damage in non-irradiated cells [39]. 
Exosome is  another cytoplasmic mediator that is  involved 
in bystander responses. Exosomes are microvesicles and 
nanovesicles secreted from both normal and tumor cells which 
have the potential to modulate cellular processes in other cells 
through intercellular signaling. Exosomes can be released 
from the plasma membrane and are involved in the removal of 
many plasma membrane proteins. These vesicles contain sev-
eral types of messengers such as proteins, mRNAs, microR-
NAs and DNA fragments. The content of exosomes  and their 
influence on other cells highly depend on the damaged cell 
type. Exposure to ionizing radiation leads to the release of 
exosomes from irradiated cells. The frequency of secreted 
exosomes  correlates with the dead cells [40]. Since the 
exosomes have a small size, they influence cell function at 
distant tissues by traveling throughout the body [41]. One of 
the most important effects of exosomes is ROS production and 
DNA damage in other cells. Dutta et al. showed that secreted 
exosomes from breast cancer cells are able to produce ROS 
production and DNA damage in other cells [42]. Induction of 
DNA damage response following exposure to exosome has 
been demonstrated [43]. Ionizing radiation is able to change 
the composition of secreted exosomes. It has been shown that 
ionizing radiation induces the secretion of 236 proteins and 
suppress the secretion of 69 proteins from head and neck 
squamous cell carcinoma [44]. The number of released 
exosomes has also a direct relation to radiation dose [45]. In 
addition to proteins’ content, ionizing radiation changes se-
creted exosome RNAs from irradiated cells. Also, it has been 
shown that RNA and protein molecules that transfer through 
exosomes to non-irradiated cells have a synergistic effect on 
induction of bystander effect [46]. Although complete mecha-
nisms of induction of bystander effect through exosomes in 
bystander cells remain to be demonstrated, some mechanisms 
are proposed for intercellular communication through 
exosomes. The main mechanisms are stimulation of immune 
system cells such as B cells and dendritic cells and fusion of 
exosomes and transfer of its content to recipient cells. 
Exosomes are able to induce significant ROS production 
through the trigger of calcium signaling [45]. In-vitro studies 
have indicated that exosomes including cytokines and 
HMGB1, are able to induce inflammatory responses in by-
stander cells [45, 46]. micro-RNA (miRNAs) acts as media-
tors that, through exosomes, are able to initiate bystander ef-
fect through epigenetic changes [47]. Transfection of mir-21 
through exosomes is a mechanism for stimulation of ROS 
production and superoxide dismutase (SOD) suppression in 
non-irradiated cells [48]. 
2.3. Cytokines Mediated Inflammation and Tissue Injury  
 Inflammatory cytokines have a potent link to radiation-
induced carcinogenesis. Increased levels of inflammatory 
cytokines after exposure to radiation have been revealed in 
several studies. Amount and profile of releasing cytokines 
are dependent on the type and numbers of dead cells. The 
number of dead cells increases as radiation dose increases. 
Moreover, necrosis to apoptosis ratio is more obvious with 
increasing radiation dose. Although cell death through ne-
crosis stimulates secretion of inflammatory cytokines (e.g. 
IL-1, IL-6, IL-33, TNF-), apoptosis promotes tolerogenic 
responses through stimulation of secretion of anti-
inflammatory cytokines (e.g. TGF-, IL-10) [49-51]. 
Elevated levels of both inflammatory and anti-inflammatory 
cytokines in irradiated and non-irradiated lung tissue have 
been observed in previous studies [52, 53]. Increased pro-
duction of these cytokines results in overproduction of ROS, 
NO-, prostaglandins etc., that play a central role in acute and 
late effects of radiotherapy in normal tissues [54]. Migration 
of secreted cytokines from irradiated area to distant tissues 
can cause some responses similar to irradiated tissues. How-
ever, the pattern of secretion of cytokines is different be-
tween irradiated and non-irradiated tissues [53].  
2.4. Ionizing Radiation Induced DNA Oxidation and 
Damage in Carcinogenesis 
Free radical production caused by the interaction of ion-
izing radiation with water molecules and redox mediated 
biological pathways are responsible for oxidative DNA dam-
age and cell death following exposure to X or gamma rays. 
Interaction of free radicals with DNA causes formation of 
different types of DNA oxidation in both nucleus and mito-
chondria. Oxidation of DNA and also cell death through ne-
crosis or apoptosis can stimulate inflammatory responses and 
oxidative stress, leading to further DNA damage. Oxidized 
cell free DNA is elevated in cancer patients and also patients 
undergoing radiotherapy for their malignancies [55-57]. 
Among various types of oxidized DNA damage, 7,8-
dihydro-8-oxoguanine (8-oxoG) lesion is one of the most 
important forms of DNA oxidation. Thus, OGG1 is primarily 
responsible for the 8-oxoG removal, a mutation in this gene 
having indicated that the following exposure can amplify 
formation of oxidized DNA [58, 59]. Several studies have 
demonstrated that the release of oxidized DNA has a role in 
bystander effect. Exposure of bystander cells to oxidized free 
DNA results in ROS˚, reactive hydroxyl radical (ROH) and 
reactive nitrogen species (RNS) (NO
-
, peroxonitrite (ONOO
-
)) 
(Fig. 1). 
2.5. miRNAs in Radiation and Carcinogenesis  
 miRNAs are a group of non-coding RNAs including 21 
to 23 nucleotides. This non-coding RNAs regulate many 
protein coding genes through targeting and silencing of es-
pecial mRNAs. The miRNAs levels change in stress condi-
tions and affect factors associated with carcinogenesis such 
as proliferation, cell death, metabolism and also tumor sup-
pressors or oncogenes [60, 61]. Change in miRNAs function 
was shown in several malignancies, such as lung cancer, 
thyroid, prostate, breast, colorectal, liver, lymphoma, and 
pancreas [62]. Studies have been showing that the expression 
of miRNAs is dependent on tissue type and age [63, 64]. 
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Moreover, following exposure to ionizing radiation, the ex-
pression of miRNAs occurs in tissue- and sex-specific man-
ners [65, 66]. The basic mechanism involved in the expres-
sion of a specific miRNA following irradiation remains un-
known, however, increased level of miRNAs is dependent on 
radiation dose and increase in  ROS production [67]. 
Although there is no  direct relationship between radiation 
dose and numbers of upregulated or downregulated miR-
NAs, some studies have proposed a relation between radia-
tion damage and change in some serum levels of miRNAs 
[68-70]. Increased or decreased serum levels of miRNAs can 
stimulate upregulation or suppression of important genes 
related to carcinogenesis in different tissues as a tissue-
specific manner.  
2.6. DNA Damage Responses in Radiation-Induced In-
flammatory Responses 
In addition to cell death, damage to genetic content off 
cells stimulates inflammatory responses [71]. DNA damage 
response (DDR) plays a key role in various pathologies such 
as chronic inflammation and carcinogenesis. DDR is includ-
ing some different signaling pathways, including homolo-
gous recombination (HR), Non-homologous end joining 
(NHEJ), mismatch repair (MMR), single-strand break repair 
(SSBR), base excision repair (BER) and nucleotide excision 
repair (NER). Although the complete interrelations between 
DDR and inflammation remain to be elucidated, studies pro-
posed that innate immune system and DNA damage repair 
have a potent effect on each other [72]. Maybe the best ex-
ample is interrelations between DDR and NF-B. There are 
several studies which indicated that DDR can stimulate 
regulation of NF-B, and NF-B is necessary for stimulation 
of DNA damage repair. NF-B stimulates HR through 
changes in cell cycle, as well as through activation of p53, 
BRCA1 and RAD51 [73]. On the other hand, DNA damage 
stimulates upregulation of inflammatory responses via 
activation of NF-B in a positive feedback loop [74, 75].  
Studies proposed that DDR plays an important role in the 
detection of fragmented DNA in the cytoplasm. Some DNA 
damage repair enzymes such as Ku70 and the DNA depend-
ent protein kinase (DNA-PK) can stimulate inflammatory 
responses after detection of fragmented DNA. For example, 
Ku70 and DNA-PK which are involved in the initiation of 
NHEJ can stimulate the production of interferon (IFN) and 
IL-1 [76, 77]. Also, Rad50 which plays a key role in the re-
pair of double strand breaks via contribution in complex of 
MRN (Mre11, Rad50 and NBS1) is involved in the upregu-
lation of NF-B and secretion of IL-1 [78]. The Poly(ADP-
ribose) polymerase-1 (PARP-1) is another enzyme that has 
some roles in apoptosis, cell cycle and DDR [79]. This en-
zyme stimulates regulation of NF-B and some inflamma-
tory cytokines such as TNF- and IL-6 [80]. 
3. BYSTANDER EFFECTS/NON-TARGETED EF-
FECTS MEDIATED MECHANISMS THROUGH SEV-
ERAL SIGNALING CASCADES 
3.1. Clastogenic Factors Regulation-Modulation in Ra-
diation Carcinogenesis and Radiotherapy 
 The evaluation of people that have been exposed to 
high doses of ionizing radiation caused by nuclear disaster 
or radiotherapy indicates the presence of clastogenic factors 
[81, 82]. These factors are able to cause breakdown in 
DNA structure and the resulting mutagenesis that may in-
crease the risk of secondary malignancies [83, 84]. In-vitro 
studies have shown that serum derived from exposed 
individuals is capable of inducing mutation in healthy cells. 
Analysis showed abnormal upregulation of factors involved 
in Reduction-Oxidation (Redox) system [85, 86]. Although, 
complete mechanisms remained unknown, in-vitro and in-
vivo studies have shown the role of various factors that 
may be released from irradiated cells, eventually affecting 
the normal function of non-irradiated cells in distant tissues 
[82, 85, 87].  
 
Fig. (1). Radiation interaction with cells causes release of multiple interacting factors including ROS˚, RNS˚, ROH˚, inflammatory cytokines, 
oxidized DNA, miRNA and exosomes. Although interaction with DNA is the main reason for release of exogenous clastogenic factors, while 
the interaction with organelles such as lysosome, membrane and mitochondria may also be involved.  
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 Some studies have confirmed the increased level of 
some clastogenic factors in serum levels of irradiated peo-
ples. Also, irradiation can downregulate some serum levels 
of factors involved in the regulation of carcinogenesis proc-
ess. Based on studies that have been conducted so far, it 
seems that immune system mediators and miRNAs have two 
important factors. Increased serum levels of several inflam-
matory and also some anti-inflammatory cytokines have 
been seen in patients after they had undergone radiotherapy. 
The level of change in these cytokines has a direct relation to 
toxicity level in irradiated tissues.  
 Exposure to radiation changes profile of factors involved 
in epigenetic modulation of carcinogenesis such as exosomes 
and miRNAs. An in-vivo study has shown that exposure to 
radiation causes upregulation of serum level of miR-33, miR-
152, miR-199a, miR-744 that affect bystander tissues [88]. 
Although some of these miRNAs including miR-33, miR-152 
have tumor suppressor activity, miR-199a and miR-744 are 
thought to play a key role in the promotion of some malignan-
cies such as nasopharyngeal, gastric and lung cancer [89-92]. 
 On the other hand, upregulation of some miRNAs such 
as mir-21 involved in oncogenic process has been revealed 
in targeted and non-targeted tissues and also in serum level 
of irradiated patients  [93-95]. Upregulation of mir-21 has 
been observed to be associated with some malignancies such 
as non-small cell lung carcinoma, glioma and breast cancer 
[96-99]. 
 It seems that local irradiation causes upregulation or 
downregulation of several miRNAs that are involved in on-
cogenic process. Upregulation of miRNAs increases serum 
levels of them that affect the expression of target genes in 
non-irradiated tissues. Moreover, downregulation of miR-
NAs with tumor suppressor properties may increase the ac-
tivity of oncogenes in distant tissues. Nonetheless, it highly 
depends on tissue and tumor genesis. However, increased 
level of some miRNAs such as mir-21 may result in some 
other mediators including TGF-.  
3.2. NF-B Regulation and Functions and Radiation 
 NF-B belongs to a family with most important tran-
scription factors regulating the expression of a large number 
of genes involved in cellular processes, such as inflamma-
tory responses, cellular growth, developmental processes and 
apoptosis. NF-B is negatively regulated by IkB proteins. A 
sheer number of evidences have shown an increased expres-
sion of NF-B in both directly irradiated and bystander cells. 
NF-B plays a key role in the upregulation of ROS and NO- 
producing enzymes, including COX-2, iNOS and NADPH 
Oxidases [100]. Inhibition of NF-B has shown a decrease in 
COX-2 and iNOS gene expression in both directly irradiated 
and bystander cells [101]. Lam et al. showed the regulation 
of N-kB in irradiated cells is crucial for bystander response 
in non-irradiated cells [102]. This may indicate that NF-B is 
necessary for initiation and secretion of clastogenic factors 
from irradiated cells. On the other hand, clastogenic factors 
such as inflammatory cytokines are able to stimulate the ex-
pression of NF-B and redox system in bystander cells. 
3.3. Lysosomes Functions and Radiation 
 Lysosomes are intracellular organelles containing acid 
hydrolyases in their lumen. The acid hydrolyases within this 
organelle serving as the degradative agent for the autophagy 
processes. The acidic pH of hydrolyases such as proteases, 
esterases, DNase II, phosphatases, nucleases and etc. are 
able to degrade a wide variety of molecular targets including 
DNA structure [103]. Recent studies have demonstrated that 
defective autophagy mediated by lysosomal enzymes leads 
to accumulation of DNA damage in cells [104, 105]. Expo-
sure to radiation and production of ROS can induce lysoso-
mal permeability and release of DNase Ii and acid sphin-
gomylinase [106]. The role of these enzymes in chromosome 
aberration and cell death has been indicated previously [107, 
108]. Also, acid sphingomylinase is involved in radiation 
induced apoptosis through the activation of ceramide syn-
thase [109, 110]. Bright et al. evaluated lysosomal changes 
in direct irradiated and bystander human fibroblast cells fol-
lowing irradiation. Their results showed a significant 
lysosomal damage and permeability during  24 hours post 
irradiation in both irradiated and bystander cells. As well as 
this result showed that lysosomal changes have  direct rela-
tion to ROS level [111]. 
3.4. Protein Kinases and Epigenetics in Radiation By-
stander Effects Interactions 
 Protein kinases are the largest enzyme family involved 
in cell signal transduction [112, 113]. So far more than 500 
different types of protein kinases have been identified based 
on biochemical studies and human genome sequencing 
[114]. Protein kinases regulate many fundamental cellular 
processes through catalyzing the transfer of the phosphate 
group from an ATP molecule (as a source of energy in cells) 
to serine, tyrosine or threonine residues in proteins [115]. 
Protein kinases work in concert with  intersecting signaling 
cascades to regulate various vital cell processes such as cell 
growth, metabolism, division, apoptosis and motility. So, 
disruption of protein kinases signaling can have profound 
effects on cell fate. Abnormal regulation of protein kinases 
has been seen in a broad range of cancers [116, 117].  
The role of protein kinases in different responses to ion-
izing radiation such as radiosensitivity, apoptosis,  etc., has 
been detected [118, 119]. The role of some protein kinases in 
bystander effect has been revealed. Based on the studies that 
have been conducted so far, mitogen-activated protein 
kinases (MAPKs), protein kinase B and protein kinase C are 
involved in ROS production and oxidative damage in by-
stander cells.  
3.4.1. Mitogen Activated Protein Kinases (MAPKs) Func-
tions and Radiation Bystander Effects Interactions 
 MAPKs, a group of protein kinases, play a pivotal role 
in regulating gene expression in response to extracellular 
signals such as mitogens, cytokines, growth factors and oth-
ers. MAPKs control basic cellular processes such as stress 
responses, survival, differentiation, proliferation, migration, 
growth and apoptosis [120, 121]. The best-known genes 
among MAPKs are p38 isoform, the extracellular signal-
regulated kinases 1 and 2 (ERK1/2) and c-Jun amino-
terminal kinases (JNKs). Exposure to alpha particles cause 
rapid phosphorylation of ERK1/2, c-Jun, and p38 and their 
downstream proteins in bystander human fibroblasts cells. 
The activation of MAPKs and downstream proteins attenu-
ated SOD or catalase suggesting that superoxide and hydro-
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gen peroxide are involved in the activation of MAPKs, and 
subsequent chromosome aberrations in bystander cells [122]. 
Additionally, both ERK and JNK, but not p38 pathways are 
shown as activated and key bystander effected proteins in 
HPV-G cells. Calcium ions released from the endoplasmic 
reticulum play a key role in this pathway [123].  
3.4.2. Protein Kinase B (PKB) Functions and Radiation 
Bystander Effects Interactions  
 The role of Protein Kinase-B (Akt) in resistance of cells 
to radiation induced apoptosis has been analysed previously 
[124]. Akt is involved in the formation of micronuclei (MN) 
in bystander affected cells. They showed rapid phosphoryla-
tion of Akt that caused activation of mammalian target of 
rapamycin (mTOR) pathway in non-irradiated cells. Also, 
they showed the activation of Akt/mTOR  independent of 
nucleus DNA damage in irradiated cells. The results indi-
cated that the exposure of cytoplasm to ionizing radiation or 
free radicals is responsible for DNA damage in bystander 
cells [125].  
3.4.3. Protein Kinase C (PKC) Functions and Bystander 
Effect Interactions  
 Protein Kinase Cs (PKCs) have basic roles in many in-
tracellular processes, including cell survival, regulation of 
cell cycle, differentiation, apoptosis etc. PKC including fam-
ily kinases are classified into sub-families according to acti-
vation mechanisms. Conventional PKC isoforms (cPKC) 
include PKC, I, II and , the novel PKC (nPKC) is com-
posed of PKC, PKC, PKC and PKC, and the atypical 
PKC (aPKC) isoforms are PKC and PKC	 [126]. The acti-
vation of PKC in response to stress situations such as expo-
sure to radiation has been demonstrated in various studies 
[127, 128]. The role of some isoforms of PKC in bystander 
cells has been confirmed. Translocation of PKC from cyto-
sol to the cell membrane is involved in ROS production and 
oxidative damage in bystander cells. It has been shown that 
upregulation of PKC amplifies the amount of the TNFR1 
on the cell membrane that results in increased  expression of 
ERK and COX-2, and mutagenesis in bystander cells [129]. 
Activation of PKC is related to other transcription factors 
such as NF-
B, MAPKs and inflammatory cytokines such as 
TNF, IL-6. Also, this PKC isoform potentiates cytokine 
secretion by macrophages through stimulation of TLR4 and 
TLR2 [130].  
Hu et al. showed that PKC gene is upregulated by 3-fold 
in the human primary fibroblast cells after co-culture with 
cells irradiated by -particles. Further analyses showed that 
upregulation of PKC is involved in DNA damaged by-
stander cells [131]. Although the downstream signaling for 
this pathway was not detected, it is possible that the activa-
tion of TNF, ERK and other downstream genes such as 
COX-2 was  involved in bystander effect signaling through 
PKC [132-134].  
 The expression of some other isoforms of the PKC was 
evaluated, including PKC-II, PKC-/ and PKC- in the 
bystander human lung fibroblast cells. The results showed 
up-regulation of all three isoforms of PKC in bystander cells 
[135]. The role of these isoforms of PKC in the promotion of 
COX-2 gene expression and carcinogenesis has been con-
firmed [136, 137]. It seems that COX-2 is the main down-
stream enzyme as a source of ROS production and DNA 
damage for different types of PKC in bystander effect and 
affected cells.  
3.5. Toll-like Receptor 9 (TLR9)  
 As discussed previously, cellular exposure to radiation 
induces oxidized DNA and exosomes. In addition to stimula-
tion of inflammatory responses from irradiated cells, these 
mediators can directly migrate to non-irradiated cells and 
stimulate ROS production. Exosomes released from irradi-
ated cells has the capability to increase the amount of ROS 
and double strand DNA breaks but not NO- in bystander 
cells. Analyses showed that ROS production is dependent on 
TLR9 signaling pathway [138]. TLR9 on bystander cells can 
detect exosomes and oxidized DNA which stimulate ROS˚ 
production [139, 140]. Based on several studies, it has been 
observed  that TLR9 through NF-
B pathway is  responsible 
for ROS production after exposure to oxidized DNA or 
exosomes [141-144]. 
3.6. Epigenetic Regulation of Cell Cycle, miRNA, DNA 
Methylation, Oncogenes and Radiation Bystander Effect 
Interactions 
 Some studies have shown deregulation of miRNAs asso-
ciated with cell cycle, apoptosis and DNA hypomethylation 
in non-targeted tissues. Local irradiation causes down-
regulation of miR-23a and miR-23b in both male and female 
and also down-regulation of miR-24 in the male. These 
changes paralleled an increase in the expression of p38 and 
CXCL12 protein. Down regulations of miR-23 and miR-24 
cause upregulation of CXCL12. This cytokine is able to in-
duce secretion of cytoplasmic Ca
2+
. In in-vitro studies, Ca
2+
 
flux was observed in bystander cells and rapid Ca
2+
 flux was 
found to be involved in oxidative DNA damage [9].  
 Upregulation of mir-16 as a suppressor of Bcl-2 in by-
stander cells is involved in cell apoptosis. The overexpres-
sion of Bcl-2 contributes to the malignant phenotype in some 
malignancies such as chronic lymphocytic leukemia. On the 
other hand, upregulation of the miR-29 family that targets 
MCL1 may sensitize bystander cells to apoptosis. These 
changes are associated with increased apoptosis. Addition-
ally, some changes in miRNAs expression may be due to the 
upregulation of c-MYC. c-MYC is a proto-oncogene which 
controls proliferation, cell cycle and apoptosis. c-MYC 
causes upregulation of miR-17 and -20a that stimulates cell 
proliferation [145].  
Upregulation of oncogenes such as c-MYC may be re-
lated to hypomethylation due to DNA damage and suppres-
sion of DNA methyltransferases (DNMT) expression. Local 
irradiation of a limited area can cause hypomethylation in 
distant non-irradiated tissue. Local brain irradiation causes 
downregulation of DNMT1, DNMT3a and DNMT3b in 
spleen. However, persistent hypomethylation is due to sup-
pression of DNMT3a. miRNAs analyses have been shown 
that overexpression of miR-194 in non-irradiated spleen is 
responsible for this. miR-194 can target both DNMT3a and 
MeCP2 [7] (Fig. 2). 
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4. TISSUE AND SEX DEPENDENT BYSTANDER RE-
SPONSES 
A series of experiments has reported the role of tissue 
and sex in DNA damage and inflammatory responses in both 
targeted and non-targeted cells and tissues. Evidences have 
shown that patterns of radiation-induced mutation and sub-
sequent gene expression and epigenetic changes, as well as  
second malignancies occur at different frequencies in males 
and females [146-149]. Korturbash et al. showed that local 
cranial irradiation of mice results in a sex-dependent and 
tissue dependent induction of DNA damage and alterations 
in global DNA methylation. They showed that although non-
targeted effect can cause permanent hypomethylation in the 
spleen, this effect has not been investigated for skin. Also, 
their result indicated that hypomethylation is more obvious 
for male rather than female [150]. Similar results have been 
observed  for the regulation of microRNAome and inflam-
matory responses in non-targeted tissues [151, 152]. 
5. LET DEPENDENT BYSTANDER RESPONSES 
Similar to direct irradiated cells, response of bystander 
cells is different for various types of radiations. However, 
the pattern of this responses may be different. In a study 
evaluating the formation of micronuclei for different quality 
of radiations including X-ray, carbon, neon and argon ions, 
results indicated that the number of micronuclei in bystander 
cells is more for higher LET [153]. The evaluation of by-
stander signaling markers in human lymphocytes co-cultured 
with macrophages showed that heavy carbon ions or -rays 
can increasingly  upregulate MAPKs in bystander cells com-
pared to -particles [154]. In vivo studies are need to confirm 
these funding.  
SUMMARY AND CONCLUSION 
 Although complete mechanisms of bystander effects and 
non-targeted effects need further elucidation to have solid 
practical applications that can be of benefit in cancer diagno-
sis and radiotherapy applications, studies conducted so far 
show the complexity of multiple factors and their radiation 
interactions in radiation-induced bystander effects and non-
targeted effect to various cellular, molecular and tissues and 
organ(s) targets. In-vitro and in-vivo experimental studies 
have shown that the main exogenous clastogenic factors se-
creted from irradiated cells consist of cytokines, exosomes, 
miRNAs, protein kinases, as well as oxidized DNA that are 
critically involved eventually in the upregulation or down-
regulation of affected genes and proteins, and epigenetic 
regulation. Interestingly, secretion of some of these factors 
may have no direct and/or indirect relationship to nuclear 
DNA damage. These factors are released from irradiated 
cells, tissues and organs into the bloodstream, and are af-
fected by field organs, thus appropriately termed as by-
stander effects and non-targeted effects based on  a bio-
physical phenomenon. The most important observed effects 
of these factors are free radicals generation, cytokines gen-
eration, inflammation, kinases activation, upregulation or 
downregulation of genes and enzymes and their activities in 
Redox system, increased mitochondria activity, and dysregu-
lation of antioxidant proteins activity in bystander effect tar-
geted cells, tissues and organ systems. In addition to the 
direct and indirect actions of ROS, ROH˚ and RNS˚ free 
radicals mediated DNA breaks and mutations, they are able 
to hypersensitize the mitochondria, and the lysosomal mem-
brane as targets. Free radicals-induced DNA break results in 
epigenetic hypomethylation and upregulation of some onco-
genes including c-MYC, Ras and exosomes. Additionally, 
miRNAs may directly suppress DNA methyltransferases and 
 
Fig. (2). Signaling pathways involved in DNA damage and genomic instability in non-targeted tissues. Although, complete mechanisms of 
this phenomenon remain to be known, illustrated signaling pathways are tissue-specific manner, and all of these signalings are not observed 
in all tissues. The most important factors for DNA damage include ROS, ROH and RNS, NO
-
, ONOO
-
, while other factors such as lysosomal 
enzymes, cytokines, exosomes and miRNAs are involved in oxidative stress. Mitochondria generated free radicals ROS, RNS˚ and ROH 
propagate the bystander-effect mediated injury at the affected cellular, tissue and organs. Additionally, exosomes and miRNAs may increase 
thr risk of radiation carcinogenesis without DNA damage. 
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maintenance of hypomethylation. On the other hand, upregu-
lation of some oncogenes, and also TGF- causes activation 
of other miRNAs that may amplify genomic instability in 
bystander cells, tissues and organs. All of these dynamic 
changes involved in describing radiation mediated bystander 
effects and non-targeted effects can only be viewed as a 
complex multifactorial phenomenon of cellular functions, 
genomic instability and radiation carcinogenesis, and the 
approach to and outcome to radiotherapy. Future discoveries 
and advancements in the understanding of radiation driven 
bystander effects and non-targeted effects will impact future 
utility for better understanding of radiation carcinogenesis, 
radiotherapy of cancer, effects on target and non-targeted 
tissues and organs, and their significance in targeted and 
non-targeted injury sites, and in the same milieu. Potential 
side applications of bystander effects and non-targeted ef-
fects for novel treatment modalities and therapeutics discov-
eries that can enhance protection and treatment of normal 
cells, tissues and organs from targeted cancerous cells, tis-
sues and organs must also eventually be explored. Applica-
tions to other diseases to include acute and degenerative dis-
eases novel treatment and therapeutics strategies can poten-
tially be an off-shot adaptation and application of an in-depth 
understanding of bystander effects for disease pathologies. 
Eventual discoveries of novel therapeutics that can target the 
molecular signature of radiation mediated bystander effects 
and non-targeted effects must be achieved for advancement 
of the impact of such phenomenon for radiation carcinogene-
sis and radiotherapy strategies advancements. 
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